<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel>
	<title>News on Valtrex from BioPortfolio.com</title>
	<link>http://www.BioPortfolio.com</link>
	<description>Consolidated Valtrex news from BioPortfolio.com</description>
	<pubDate>Wed, 10 Feb 2010 08:27:04 GMT</pubDate>
	<language>en</language>
<atom:link href="http://www.bioportfolio.co.uk/cgi-bin/rssnews.pl?q=Valtrex" rel="self" type="application/rss+xml" />

	
<item><title>GSK's strategy looks good</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4025730&amp;HITNO=0&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valtrex&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4025730&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2530148398%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4025730&amp;HITNO=0&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valtrex&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4025730&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2530148398%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Telegraph:</description></item>
<item><title>GSK to shed staff as it ends painkiller research</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4018440&amp;HITNO=1&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valtrex&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4018440&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2525678451%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4018440&amp;HITNO=1&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valtrex&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4018440&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2525678451%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Times Online:</description></item>
<item><title>GSK to cut jobs as it ends painkiller research</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4017455&amp;HITNO=2&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valtrex&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4017455&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2525149870%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4017455&amp;HITNO=2&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valtrex&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4017455&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2525149870%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Times Online:</description></item>
<item><title>UPDATE: GlaxoSmithKline Extends Revamp As Profits Soar</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4017169&amp;HITNO=3&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valtrex&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4017169&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2525025222%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4017169&amp;HITNO=3&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valtrex&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4017169&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2525025222%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Morningstar.com:</description></item>
<item><title>Glaxo plans more savings as Q4 beats forecasts</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4016677&amp;HITNO=4&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valtrex&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4016677&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524840948%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4016677&amp;HITNO=4&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valtrex&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4016677&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524840948%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Moneycontrol.com:</description></item>
<item><title>Glaxo drops some drug research</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4016645&amp;HITNO=5&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valtrex&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4016645&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524828803%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4016645&amp;HITNO=5&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valtrex&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4016645&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524828803%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>International Business Times UK:</description></item>
<item><title>Glaxo plans more savings</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4016638&amp;HITNO=6&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valtrex&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4016638&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524825711%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4016638&amp;HITNO=6&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valtrex&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4016638&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524825711%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>International Business Times UK:</description></item>
<item><title>Glaxo drops some drug research</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4015867&amp;HITNO=7&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valtrex&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4015867&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524553250%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4015867&amp;HITNO=7&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valtrex&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4015867&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524553250%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Tiscali:</description></item>
<item><title>Glaxo plans more savings as flu windfall dwindles</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4015613&amp;HITNO=8&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valtrex&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4015613&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524453954%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4015613&amp;HITNO=8&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valtrex&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4015613&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524453954%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Business Spectator:</description></item>
<item><title>Glaxo to slice $792M more from costs</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4015345&amp;HITNO=9&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valtrex&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4015345&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524374504%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4015345&amp;HITNO=9&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valtrex&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4015345&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524374504%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>FiercePharma:</description></item>
<item><title>Glaxo drops some drug research</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4015294&amp;HITNO=10&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valtrex&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4015294&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524357095%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4015294&amp;HITNO=10&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valtrex&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4015294&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524357095%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Interactive Investor:</description></item>
<item><title>Glaxo plans more savings as Q4 beats forecasts</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4015116&amp;HITNO=11&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valtrex&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4015116&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524284872%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4015116&amp;HITNO=11&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valtrex&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4015116&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524284872%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Reuters India:</description></item>
<item><title>Glaxo plans more savings as Q4 beats forecasts</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4014272&amp;HITNO=12&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valtrex&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4014272&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523951527%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4014272&amp;HITNO=12&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valtrex&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4014272&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523951527%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>DNA India:</description></item>
<item><title>UPDATE 3-Glaxo drops some drug research in efficiency drive</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4014188&amp;HITNO=13&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valtrex&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4014188&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523919366%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4014188&amp;HITNO=13&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valtrex&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4014188&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523919366%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Reuters UK:</description></item>
<item><title>Glaxo drops some drug research</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4014173&amp;HITNO=14&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valtrex&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4014173&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523913091%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4014173&amp;HITNO=14&amp;MSIZE=53&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valtrex&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4014173&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523913091%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Yahoo! UK and Ireland:</description></item>
</channel></rss>